Rendering

Component: (Network and Table)
Network
00000025 - Disclosure - 5. EQUITY TRANSACTIONS (Tables)
(http://aethlonmedical.com/role/EquityTransactionsTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000882291 (http://www.sec.gov/CIK)
Equity [Abstract]Period [Axis]
2015-04-01 - 2016-03-31
Equity [Abstract]
 
Summary of warrant activity
   Fiscal Year Ended March 31, 
   2016   2015 
   Warrants   Weighted Average
Exercise Price		   Warrants   Weighted Average
Exercise Price		 
Outstanding, beginning of year   1,430,738   $6.84    1,414,190   $5.00 
Granted   746,657   $6.30    806,478   $8.46 
Exercised   (12,049)  $2.15    (590,659)  $4.29 
Cancelled/Forfeited   (1,252)  $2.10    (199,271)  $7.11 
Outstanding, end of year   2,164,094   $6.68    1,430,738   $6.84 
Exercisable, end of year   2,164,094   $6.68    1,430,738   $6.84 
Weighted average estimated fair value of warrants granted       $5.11        $11.83 
  
Assumptions used for warrants granted
   Year Ended March 31, 
   2016   2015 
Risk free interest rate   1.70%    0.79%-2.29% 
Average expected life   5 years    5 to 7 years 
Expected volatility   98.6%    87.8% - 107.4% 
Expected dividends   None    None 
  
Summary of warrant activity exercisable and outstanding
    Warrants Outstanding         Warrants Exercisable 
Range of
Exercise Prices		   

Number

Outstanding

    

Weighted Average

Remaining

Life (Years)

    

Weighted Average

Exercise Price

    

Number

Outstanding

    

Weighted Average

Exercise Price

 
$5.00 or Below   515,533    2.78   $2.63    515,533   $2.63 
$5.20 - $9.00   1,351,632    3.85   $6.46    1,351,632   $6.46 
$9.65 - $15.00   296,929    3.71   $14.70    296,929   $14.70 
    2,164,094              2,164,094      
  
Summary of the stock options outstanding
   Fiscal Year Ended March 31, 
   2016   2015 
   Options  

Weighted Average

Exercise Price

   Options  

Weighted Average

Exercise Price

 
Outstanding, beginning of year   501,690   $11.00    522,668   $12.50 
Granted   –    N/A     59,453   $9.50 
Exercised   –    N/A     (1,000)  $9.50 
Cancelled/Forfeited   (63,143)  $11.45    (79,431)   $18.76 
Outstanding, end of year   438,547   $10.94    501,690   $11.00 
Exercisable, end of year   388,414   $11.53    418,923   $12.00 
Weighted average estimated fair value of options granted        N/A        $9.50 
  
Weighted average assumptions used to estimate the fair value information
Risk free interest rate 2.60%
Average expected life 10 years
Expected volatility 90.23%
Expected dividends None
  
Detail of options outstanding and exercisable by exercise price
      Options Outstanding    Options Exercisable 
 
Exercise Prices		    

Number

Outstanding

    

Weighted Average

Remaining

Life (Years)

    

Weighted Average

Exercise

Price

    

Number

Outstanding

    

Weighted Average

Exercise

Price

 
 $3.80 - $9.50    190,547    7.70 years   $6.03    140,414   $5.91 
 $12.50    163,000    4.39 years   $12.50    163,000   $12.50 
 $18.00 - $20.50    85,000    2.02 years   $19.03    85,000   $19.03 
      438,547              388,414      
  
Schedule of stock-based compensation
   Fiscal Year Ended 
   March 31, 2016   March 31, 2015 
Vesting of stock options  $202,844   $416,481 
Total Stock-Based Compensation  $202,844   $416,481